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Abstract 
 
The natural-resistance associated macrophage protein 1, Slc11a1, is a phagolysosomal 
transporter for protons and divalent ions including iron, that confers host protection against 
diverse intracellular pathogens including Salmonella. We investigated and compared the 
regulation of iron homeostasis and immune function in RAW264.7 murine phagocytes stably 
transfected with non-functional Slc11a1 and functional Slc11a1 controls in response to an 
infection with Salmonella enterica serovar Typhimurium (S. Typhimurium).  We report that 
macrophages lacking functional Slc11a1 displayed an increased expression of transferrin 
receptor 1, resulting in enhanced acquisition of transferrin-bound iron. In contrast, cellular 
iron release mediated via ferroportin 1 was significantly lower in Salmonella-infected 
Slc11a1-negative macrophages in comparison to phagocytes bearing Slc11a1. Lack of 
Slc11a1 led to intracellular persistence of S. Typhimurium within macrophages which was 
paralleled by a reduced formation of nitric oxide, tumour necrosis factor-alpha and 
interleukin-6 in Slc11a1-negative macrophages following Salmonella infection, whereas 
interleukin-10 production was increased. Moreover, Slc11a1-negative phagocytes exhibited 
higher cellular iron content, resulting in increased iron acquisition by intracellular Salmonella. 
Our observations indicate a bifunctional role for Slc11a1 within phagocytes. Slc11a restricts 
iron availability, which firstly augments pro-inflammatory macrophage effector functions and 
secondly concomitantly limits microbial iron access. 
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Introduction 
 
The natural resistance-associated macrophage protein 1, Slc11a1 (solute carrier family 11 
member 1, formerly Nramp1), modifies macrophage activation, thus conferring innate 
resistance to intracellular pathogens as well as susceptibility to certain autoimmune diseases 
(Blackwell et al., 1999, Canonne-Hergaux et al., 1999). Slc11a1 is an integral membrane 
protein expressed in the late phagolysosomes of macrophages and in intracellular 
compartments of neutrophils and dendritic cells (Gruenheid et al., 1999, Valdez et al., 2008a). 
Although Slc11a1 primarily acts as a proton-dependent transporter for divalent ions such as 
iron or manganese, it also exerts pleiotropic effects on innate immune functions. For instance, 
Slc11a1 modulates the production of chemokines and cytokines such as macrophage 
inflammatory protein 1-alpha (Mip-1α), tumour necrosis factor-alpha (TNF-α), interleukin 
(IL)-1ß, and the formation of reactive oxygen and nitrogen species (ROS and RNS, 
respectively), as well as antigen processing and presentation (Blackwell et al., 2003, Forbes et 
al., 2001, Kuhn et al., 1999, Nevo et al., 2006, Fritsche et al., 2003, Valdez et al., 2008b). 
Slc11a1-mediated resistance to intramacrophage microbes covers distinct taxonomically 
unrelated pathogens such as Salmonella, Mycobacterium and Leishmania species, and part of 
this appears to be linked to its capacity to transport iron (Forbes et al., 2001, Huynh et al., 
2008). While Slc11a1 may shift iron into phagolysosomes (Zwilling et al., 1999, Kuhn et al., 
1999, Kuhn et al., 2001), where redox-active ferrous iron may directly support the formation 
of ROS in the Fenton reaction, evidence is abundant that Slc11a1 expression is associated 
with iron efflux out of phagolysosomes and subsequently out of macrophages (Atkinson et al., 
1999, Mulero et al., 2002, Fritsche et al., 2007), supporting the hypothesis that Slc11a1 may 
deprive intracellular microorganisms of essential iron. 
Notably, the efficacy of several macrophage immune functions is strongly influenced by iron. 
Whereas trace amounts of iron are required for the generation of ROS, several pathways of 
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host protection supported by mononuclear phagocytes, including those driven by interferon-
gamma (IFN-γ), are impaired by elevated macrophage iron content (Weiss, 2002). For 
instance, macrophage iron overload results in reduced expression of TNF-α, inducible nitric 
oxide synthase (iNOS) and major histocompatibility complex (MHC) class II, thus 
simultaneously impairing cytokine production, bacterial elimination via RNS and antigen 
presentation (Weiss et al., 1994, Oexle et al., 2003, Nairz et al., 2007, Recalcati et al., 1998). 
Importantly, TNF-α signalling and iNOS expression are of pivotal importance in innate 
immunity against Salmonella Typhimurium (Vazquez-Torres et al., 2000, Vazquez-Torres et 
al., 2001, Mastroeni et al., 2000). Since iron exerts inhibitory effects on these antimicrobial 
pathways, iron overload of the mononuclear phagocyte system is associated with an increased 
incidence of infections, as seen in secondary iron overload (Nairz et al., 2006, Rahav et al., 
2006, Wang et al., 2003). 
Given the importance of iron for innate immune functions and metabolism, macrophages 
tightly control cellular iron homeostasis by regulating both transmembraneous iron fluxes and 
intracellular iron storage (Knutson et al., 2003a, Weiss, 2005, Theurl et al., 2005, 
Oppenheimer, 2001). Phagocytes can acquire non-transferrin-bound iron (NTBI) via divalent 
metal transporter 1 (Dmt1) and transferrin-bound iron (TBI) via transferrin receptor 1 (TfR1). 
The phagocytosis of senescent erythrocytes provides macrophages with heme-iron, which is 
released upon enzymatic degradation by heme oxygenase 1 (Hmox1). Surplus iron can be 
either stored within ferritin or exported out of macrophages via ferroportin 1 (Fpn1), thus 
being recycled to the circulating pool of TBI (Bonnah et al., 2004, Nairz et al., 2006, Hentze 
et al., 2004). 
As a consequence of its involvement in central metabolic processes, iron directly promotes 
the growth and proliferation of microorganisms by serving as an essential nutrient (Weinberg, 
1998, Weinberg, 2000, Schaible et al., 2005). In fact, with the sole exception of Borrelia 
burgdorferi, which uses manganese in place of iron-sulfur clusters in its metabolic enzymes, 
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all mammalian pathogens require iron (Schaible et al., 2004). Accordingly, microbial iron 
uptake mechanisms promote virulence whereas genetic deletion of iron import pathways 
reduces pathogenicity (Boyer et al., 2002, Janakiraman et al., 2000, Fischbach et al., 2006, 
Crouch et al., 2008, Jung et al., 2008, Schrettl et al., 2007, Winkelmann, 2002). The 
limitation of iron availability for pathogens is thus an effective strategy of innate host defense 
as shown in several in vitro and in vivo studies (Ibrahim et al., 2007, Nairz et al., 2007, 
Olakanmi et al., 2000, Paradkar et al., 2008, Kanti Das et al., 2008). 
To better understand the pleiotropic functions of Slc11a1 in host protection against 
intracellular pathogens, we have initiated in vitro experiments to simultaneously study iron 
homeostasis and effector functions in RAW264.7 macrophage-like cells stably transfected 
with functional (RAW-37 cells) or non-functional (RAW-21 cells) Slc11a1 during infection 
with S. Typhimurium. 
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Results 
 
Effects of Slc11a1 on iron acquisition, iron mobilization and iron release by Salmonella-
infected macrophages 
When investigating macrophage iron import, we found that TfR1 mRNA levels and 
transferrin-mediated iron uptake were significantly increased in RAW-21 cells lacking 
functional Slc11a1 when compared with Slc11a1-expressing RAW-37 macrophages. These 
changes were also seen in Salmonella-infected and/or IFN-γ treated cells (Figures 1A and B). 
In contrast, neither the expression of Dmt1 mRNA nor the uptake of NTBI differed 
significantly between Slc11a1-non-expressing RAW-21 and Slc11a1-expressing RAW-37 
cells (Supplementary figures 1A and B). Moreover, while Fpn1 mRNA levels were not 
different between solvent-treated RAW-21 and RAW-37 cells, Salmonella infection resulted 
in approximately 80% lower Fpn1 mRNA expression in Slc11a1-dysfunctional RAW-21 cells 
(P < 0.05). This difference was also apparent in Salmonella-infected phagocytes subsequently 
stimulated with IFN-γ (Figure 1C). In parallel with the reduced Fpn1 expression, cellular iron 
efflux was approximately 95-100% lower in Salmonella-infected RAW-21 cells with or 
without IFN-γ-stimulation, in comparison to Slc11a1-expressing RAW-37 cells subjected to 
the same treatment (Figure 1D). The observed changes in TfR1 and Fpn1 mRNA levels were 
similar to their levels of protein expression (Figure 2). Of relevance, levels of hepcidin 
antimicrobial peptide (Hamp) mRNA were not altered upon S. Typhimurium infection and did 
not differ between RAW-21 and RAW-37 cells (data not shown). 
After 24 hours, Hmox1 transcripts were significantly induced in Salmonella-infected 
phagocytes and further enhanced upon addition of IFN-γ. However, Hmox1 mRNA and 
protein levels were comparable in RAW-21 and RAW-37 cells. Similarly, mRNA levels of 
the heme-exporting feline leukaemia virus, subgroup C, receptor (Flvcr) were not different 
between the two cell lines (data not shown). 
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Effects of Slc11a1 on cellular iron content and on intracellular iron traffic in Salmonella-
infected macrophages 
To examine the effects of Slc11a1 on iron availability within Salmonella-infected 
macrophages, we first examined the expression of the iron storage protein ferritin. Salmonella 
infection resulted in a marked enhancement of ferritin mRNA and protein expression in both, 
RAW-21 and RAW-37 cells, in comparison to unstimulated cells. However, Slc11a1 did not 
influence ferritin expression as no difference was observed between these two cell lines under 
any of the experimental conditions (Figures 3A and B). 
Nevertheless, as ferritin expression at the protein level under inflammatory conditions is 
influenced by both iron concentrations and inflammatory stimuli, we determined cellular iron 
content by means of atomic absorption spectrometry. Iron content decreased following 
Salmonella infection in both cells types, but RAW-21 cells were found to have a 43-63% 
higher iron content than Slc11a1-expressing RAW-37 cells under the same conditions (P < 
0.05, Figure 3C). 
 
Impact of Slc11a1 on macrophage immune effector functions 
To better understand the effects of Slc11a1 on innate immune effector functions, we 
determined the concentrations of macrophage-derived mediators in culture supernatants of 
RAW-21 cells and Slc11a1-expressing RAW-37 stimulated with IFN-γ and/or infected with 
Salmonella. Notably, the production of RNS, measured as the oxidation end-product nitrite in 
cell culture supernatants, was significantly lower in RAW-21 cells than in Slc11a1-
expresssing RAW-37 cells (Figure 4A). This may be due to a transcriptional regulation as we 
found significantly decreased expression of inducible nitric oxide synthase (iNOS) mRNA in 
Salmonella-infected RAW-21 macrophages in comparison to RAW-37 cells (Supplementary 
figure 2A). In contrast, Slc11a1 had no effect on the transcription of phox-p47 nor the 
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production of ROS, the latter determined by measurement of total oxidative capacity (TOC) 
in cell culture supernatants (data not shown and supplementary figure 2B). Intriguingly, the 
presence of Slc11a1 also correlated with the expression of several macrophage-derived 
cytokines. Upon infection with Salmonella and with or without the addition of IFN-γ, RAW-
21 cells lacking functional Slc11a1 secreted significantly lower amounts of TNF-α and IL-6 
(Figures 4B and 4C) and substantially higher amounts of IL-10 in comparison to Slc11a1-
expressing RAW-37 macrophages treated identically (Figure 4D). In contrast, IL-1ß levels in 
cell culture supernatants did not differ markedly between the two cell lines (Supplementary 
figure 2C). Similarly, Slc11a1 did not influence levels of IL-18 or IL-23 mRNA (data not 
shown). Of interest, RAW-21 also displayed lower mRNA levels of chemokines monocyte 
chemoattractant protein (Mcp)-1 and Mip-1α, whereas no effect of Slc11a1 was observed 
with respect to Ccl-5 or Cxcl-10 mRNA expression (data not shown). 
Electrophoretic mobility shift assays were performed to determine whether the impaired 
production of pro-inflammatory mediators by Salmonella-infected and IFN-γ stimulated 
RAW-21 cells could be attributed to specific transcriptional regulators. Slc11a1-non-
expressing RAW-21 cells exhibited higher binding affinities of the transcription factor signal 
transducer and activator of transcription (STAT)-3 in response to Salmonella infection and/or 
cytokine stimulation for 24 hours (Supplementary figure 3), as recently reported for IFN-
γ/LPS stimulation (Fritsche et al., 2008). In contrast, activation of interferon regulatory factor 
(IRF)-1, nuclear factor (NF)-κB and STAT-1 was not affected by the presence of functional 
Slc11a1 (Supplementary figure 3 and data not shown). 
 
Impact of Slc11a1 on macrophage antimicrobial activity upon IFN-γ stimulation and iron 
perturbations 
We observed increased bacterial survival in Slc11a1-non-expressing RAW-21 cells which 
became significant by 16 to 24 hours post-infection (Figure 5A), in agreement with previous 
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observations (Blackwell et al., 2001, Forbes et al., 2001, Fritsche et al., 2008). Stimulation 
with IFN-γ significantly reduced Salmonella survival in both cell types (Figure 5B). TBI 
supplementation resulted in a dose-dependent increase in Salmonella survival within RAW-21 
mononuclear phagocytes, while the presence of Slc11a1 in RAW-37 cells efficiently 
abrogated this Salmonella growth-promoting effect of iron supplementation (Figure 6A). In 
parallel, TBI dose-dependently reduced the generation of nitrite as well as the secretion of 
TNF-α by Salmonella-infected RAW-21 macrophages, which was not observed in Slc11a1-
expressing RAW-37 phagocytes (Figures 6B and 6C). Interestingly, TBI supplementation 
dose-dependently augmented IL-10 expression in infected RAW-21 cells, but the low IL-10 
levels seen in Slc11a1-functional RAW-37 cells were not changed by iron supplementation 
(Figure 6D). NTBI, delivered as ferrous sulfate, exerted similar effects on intracellular 
Salmonella survival and macrophage nitrite and cytokine production to supplementation with 
TBI (data not shown). 
 
Effects of synthetic Hamp and of an anti-TfR1 antibody on Salmonella-infected RAW-21 and 
RAW-37 macrophages 
We next investigated the effects of synthetic Hamp and of a blocking anti-TfR1 antibody, 
both of which are expected to modulate macrophage transmembraneous iron fluxes, on 
effector functions of RAW-21 cells as compared to Slc11a1-functional RAW-37 phagocytes. 
Interestingly, the addition of Hamp to Salmonella-infected macrophages increased the 
bacterial load by 55-60% in both RAW-21 and RAW-37 cells, in comparison to cells not 
treated with Hamp (Figure 7A). However, antibody-mediated blockade of TfR1 reduced the 
number of intracellular bacteria only in RAW-21, but not in Slc11a1-expressing RAW-37 
macrophages. Notably, increased concentrations of nitrite were measured in both RAW-21 
and RAW-37 macrophages following the addition of anti-TfR1 antibody (Figure 7B). In 
contrast, the addition of ferrous sulfate and Hamp impaired the generation of nitrite 
Page 9 of 50
Slc11a1 limits Salmonella iron access 10 
exclusively in Salmonella-infected RAW-21 cells, but not in infected Slc11a1-competent 
RAW-37 cells. Of note, Hamp resulted in significant inhibition of TNF-α production in both 
macrophage cell lines, whereas the addition of a blocking anti-TfR1 antibody had no 
substantial effect on the production of TNF−α in either RAW-21 or RAW-37 cells (Figure 
7C). 
 
Limitation of iron availability for intracellular Salmonella in the presence of Slc11a1 
To see whether the alterations of transmembrane iron fluxes mediated by functional Slc11a1 
may affect iron acquisition by intracellular bacteria, we directly measured the uptake of 59Fe, 
delivered as either NTBI or TBI, into internalized Salmonella. Notably, the incorporation of 
NTBI and TBI by intramacrophage bacteria was significantly higher in RAW-21 cells in 
comparison to Salmonella residing within RAW-37 cells expressing functional Slc11a1 
(Figures 8A and 8B). Of note, IFN-γ was able to further reduce the availability of both iron 
forms to phagocytosed Salmonella independently of Slc11a1. 
 
Effects of bacterial iron acquisition systems on effector functions of RAW-21 and RAW-37 
macrophages 
The effect of Slc11a1 on the survival of S. Typhimurium strains carrying mutations in entC, 
required for siderophore biosynthesis, with or without mutations in the sit and feo loci, 
required for siderophore-independent iron acquisition, was determined. Wild-type S. 
Typhimurium exhibited greater intracellular survival than mutant strains lacking siderophore 
biosynthesis, and this difference was most pronounced in RAW-21 cells (Figure 9A). RAW-
21 cells controlled the replication and survival of all S. Typhimurium strains less efficiently 
than did Slc11a1-expressing RAW-37 cells, although significant differences were only 
observed upon infection with wild-type Salmonella (Figure 9A). Interestingly, the 
intracellular growth of both wild-type and isogenic entC mutant Salmonella strains was 
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enhanced following addition of holo-transferrin to infected Slc11a1-dysfunctional RAW-21 
macrophages, whereas the entC sit feo triple mutant showed no effect. In contrast, RAW-37 
cells limited the growth of all bacterial strains whether or not supplemental holo-transferrin 
was provided.  
The production of nitrite and IL-10 was not affected by entC, sit or feo mutations (Figure 9B 
and supplementary figure 4), but higher TNF-α levels were elicited by entC and entC sit feo 
mutants following infection of RAW-21 cells (Figure 9C). Notably, holo-transferrin inhibited 
nitrite and TNF-α production by infected Slc11a1-deficient RAW-21 phagocytes but did not 
appear to affect the lower levels produced by RAW-37 cells (Figures 9B and C).  
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Discussion 
 
Herein, we provide evidence that Slc11a1 exerts multiple functions within Salmonella-
infected macrophages, simultaneously influencing both, the expression of antimicrobial 
immune responses and the access of intracellular bacteria to cellular iron. Specifically, the 
expression of Slc11a1 reduces intracellular iron levels of Salmonella-infected macrophages, 
which is exerted by at least two pathways: first, a reduction in TfR1-mediated iron uptake and 
second, the induction of Fpn1-mediated iron efflux (Figure 1). These events limit the 
availability of iron for Salmonella residing within phagosomal vacuoles. In addition, due to 
regulatory effects of iron on IFN-γ-mediated pathways in macrophages, the reduction in 
intracellular iron concentration promotes the production of TNF-α and IL-6 as well as the 
expression of iNOS (Oexle et al., 2003, Weiss et al., 1994, Nairz et al., 2008). In parallel, 
Slc11a1 either directly or via modulation of pro-inflammatory immune effector pathways 
suppresses the secretion of IL-10 (Fritsche et al., 2008). Accordingly, Slc11a1-mediated 
resistance against leishmanial parasites, mycobacteria and salmonellae is associated with a T 
helper cell type 1 (Th1) response, which favours host defense against intracellular 
microorganisms (Soo et al., 1998, Kramnik et al., 1994, Valdez et al., 2008a, Valdez et al., 
2008b). It is tempting to speculate that the increased production of pro-inflammatory 
cytokines in conjunction with the reduced production of the anti-inflammatory mediator IL-10 
may contribute to both the increased resistance to infection and the increased susceptibility to 
autoimmune disorders that are associated with Slc11a1 in both mice and humans (Blackwell 
et al., 2003). 
Intriguingly, there were differences in the iron-dependent influence of Slc11a1 on the 
generation of nitrite, TNF-α, IL-6 and IL-10 in Salmonella-infected macrophages (Figure 6). , 
While the addition of TBI dose-dependently inhibited the generation of nitrite and TNF-α 
exclusively in RAW-21 phagocytes lacking Slc11a1, Slc11a1-expressing RAW-37 cells were 
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capable of producing high levels of RNS and TNF-α and of secreting even larger amounts of 
IL-6 upon gradually increasing TBI supplementation. The opposite was true with IL-10 
formation. While Slc11a1-positive cells could limit IL-10 secretion in the face of increasing 
iron levels, Salmonella-infected Slc11a1-negative macrophages responded to the exposition to 
high concentrations of TBI by producing increasing amounts of IL-10. These differential 
effects were also observed in response to stimulation with IFN-γ and/or LPS (Fritsche et al., 
2008), suggesting that they may not indirectly result from the increased Salmonella burden 
within RAW-21 cells. Being aware of the differences in iron handling between Slc11a1-
positive and -negative macrophages and of the fact that iron differently affects pro- and anti-
inflammatory immune pathways, these observations can thus be traced back to limitation of 
labile cytoplasmic iron by Slc11a1-expressing cells. Accordingly, we also suggest that 
Slc11a1-expressing cells can rapidly shift iron from the cytoplasm out of cells via Fpn1. In 
contrast, iron accumulates in Slc11a1-negative cells and then exerts its negative effects on 
pro-inflammatory immune effectors pathways while promoting the formation of IL-10 
(Fritsche et al., 2008, Knutson et al., 2003b, Mencacci et al., 1997, Oexle et al., 2003, 
Oppenheimer, 2001, Weiss et al., 1999). 
To date, the underlying molecular mechanisms by which Slc11a1 concomitantly increases the 
production of TNF-α, IL-6 and RNS and differently affects the expression of immune genes 
have not been elucidated.. Since TNF-α, IL-6, Mcp-1, Mip-1α and iNOS mRNA levels are 
substantially higher in Slc11a1-expressing RAW-37 cells (Supplementary figure 2 and 
additional data not shown), a transcriptional or post-transcriptional mechanism may be 
involved. Notably, Salmonella-infected and/or IFN-γ-stimulated RAW-21 and RAW-37 
macrophages showed comparable binding activities of the transcription factors IRF-1, NF-κB 
and STAT-1, all of which are pivotal for the up-regulation of iNOS in response to 
inflammatory stimuli (Fritsche et al., 2003). However, these differences were only observed 
at late time-points, whereas differential cytokine mRNA expression was evident earlier. 
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Therefore, the increased activation of STAT-3 in LPS- or Salmonella-stimulated RAW-21 
macrophages is presumably a consequence rather than a cause of the higher IL-10 levels 
produced by these cells. In this context, it is of considerable interest that the neutralization of 
IL-10 by specific antibodies restored the induction of TNF-α and iNOS and enhanced 
Salmonella killing of Salmonella in Slc11a1-deficient RAW-21 cells (Fritsche et al., 2008). 
Some investigators have suggested that Slc11a1 may promote TNF-α and RNS formation by 
prolonging the half-life of TNF-α and iNOS mRNAs, respectively (Brown et al., 1997), 
although we were unable to corroborate this observation (Fritsche et al., 2003). Moreover, it 
is possible that TNF-α produced in greater quantities by Slc11a1-positive macrophages 
contributes to their higher capacity to generate RNS by acting as a co-activator of iNOS 
expression (Ables et al., 2001). Thus, Slc11a1 may regulate cytokine expression via 
activation of iron- or NO-sensitive transcription factors, although we did not detect 
differential activations of NF-κB and NF-IL6 (Supplementary figure 3 and details not shown). 
Alternatively, it is possible that functional Slc11a1 may selectively stimulate certain 
macrophage functions by its ability to promote the maturation of Salmonella-containing 
phagosomes (Cuellar-Mata et al., 2002, Jabado et al., 2003). Intracellular fusion events 
involving pathogen-containing vesicles may initiate signal transduction mechanisms ensuring 
a predominately pro-inflammatory response in Slc11a1-expressing infected macrophages. 
Anyhow, regulatory interactions between iron availability and cellular immune effector 
pathways are likely to account for some of the effects of Slc11a1 on host resistance to diverse 
intracellular pathogens such as Salmonella, Mycobacterium or Leishmania spp. (Diefenbach 
et al., 1999, Mastroeni et al., 2000, Weiss et al., 1994) 
Since phagocytes are a preferred habitat for S. Typhimurium (Vazquez-Torres et al., 1999), 
the control of iron homeostasis in infected mononuclear cells is crucial for effective host 
defense against this bacterium (Collins, 2003, Theurl et al., 2005). Within macrophages, 
Slc11a1 is found exclusively in the membrane of late endosomes and phagolysosomes but has 
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not been detected in the plasma membrane (Blackwell et al., 2003, Searle et al., 1998, 
Atkinson et al., 1997, Gruenheid et al., 1999, Gruenheid et al., 1997, Canonne-Hergaux et al., 
2002, Lam-Yuk-Tseung et al., 2006). Therefore, the effect of Slc11a1 on cellular iron release 
is presumably an indirect one. This may be a consequence of the differences in immune 
activation between Scl11a1-positive and -negative macrophages, since increased formation of 
NO and oxygen radicals, as seen in Slc11a1-expressing phagocytes, can directly affect the 
orchestration of cellular iron homeostasis via iron regulatory proteins (IRPs). Specifically, NO 
and oxygen radicals modify IRP binding affinity to IREs thereby affecting ferritin and TfR1 
mRNA processing (Muckenthaler et al., 2008, Recalcati et al., 1998, Weiss et al., 1993). 
Our results show reduced acquisition of iron by intraphagolysosomal Salmonella residing 
within Slc11a1-functional cells, which strongly supports the concept that Slc11a1 shifts iron 
from the phagolysosomal compartment to the cytosolic space. An intermittent cytosolic 
accumulation of iron may affect Fpn1 and TfR1 expression via both transcriptional and 
IRP/IRE-mediated posttranscriptional control (Figures 1 and 2). In addition, the presence of 
Fpn1 in the cell surface membrane can be regulated at the posttranslational level by Hamp 
produced by activated macrophages in an autocrine fashion (Theurl et al., 2008). However, 
the cytosolic space does not appear to be the final resting location for this iron, as  in steady 
state conditions, a fall in TfR1-mediated iron uptake along with increased Fpn1-mediated iron 
export markedly reduced total macrophage iron content and the cytoplasmic labile iron pool, 
as measured by atomic absorption spectrometry (Figure 4) and electrophoretic mobility shift 
assays of IRP binding (Atkinson et al., 1999, Barton et al., 1999, Fritsche et al., 2007, Nairz 
et al., unpublished observations). Slc11a1 did not affect the expression of ferritin or the 
incorporation of 59Fe into ferritin multimers (Figure 3 and data not shown). Furthermore, we 
did not detect any effect of Slc11a1 on the expression of the heme-mobilizing enzyme Hmox1 
or the heme-exporter Flvcr in infected macrophages. Although we did not challenge 
macrophages with heme-iron, hemoglobin or erythrocytes, our results support the idea that 
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Slc11a1 modulates the cytosolic iron content. Iron-sensitive fluorogenic probes targeting 
specific organelles may be helpful in investigating Slc11a1-mediated iron fluxes between 
intracellular compartments under real-time conditions by means of microfluorescence 
imaging (Glickstein et al., 2005, Jabado et al., 2000). However, Slc11a1 leads to reduction of 
cytoplasmic iron levels and withholds the metal from pathogens residing within 
phagolysosomes. As Hamp mRNA levels were not affected by the presence or absence of 
Slc11a1, it is highly unlikely that changes in Hamp expression are responsible for the 
differences in iron export observed between RAW-21 and Slc11a1-expressing RAW-37 
macrophages. Although the blockade of Fpn1-mediated iron efflux by the addition of 
synthetic Hamp resulted in a marked increase in the microbial burden of infected phagocytes, 
Hamp treatment of infected macrophages failed to abolish the differences in bacterial survival 
between RAW-21 and RAW-37 cells, suggesting that Slc11a1-dependent antimicrobial 
actions are not dependent on Fpn1-mediated iron export (Figure 7). 
A number of studies have attempted to elucidate the biochemical function of Slc11a1, yet its 
mode of action remains a topic of some debate. Experiments with isolated phagosomes 
suggested that Slc11a1 might transport iron into these organelles to provide a catalyst for the 
production of cytotoxic ROS via the Fenton reaction (Kuhn et al., 1999, Kuhn et al., 2001, 
Zwilling et al., 1999). However, investigations using intact cells rather indicated that Slc11a1 
fluxes divalent ions such as iron and manganese out of the lumen of phagosomes into the 
cytosol (Jabado et al., 2002, Gomes et al., 1998, Forbes et al., 2003).  Moreover, the topology 
of Slc11a1 in the vacuolar membrane relative to the proton gradient indicates that the 
direction of cation transport is outward. Although we did not directly measure iron transport 
across the phagolysosomal membrane or iron concentrations within the phagolysosome, our 
demonstration of reduced iron acquisition by intraphagolysosomal Salmonella residing within 
Slc11a1-expressing cells is most consistent with the idea that Slc11a1 depletes the 
phagolysosome of iron. To the best of our knowledge, this is the first report to directly 
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compare 59Fe acquisition by an intraphagolysosomal pathogen in the presence or absence of 
functional Slc11a1. Studies with Slc11a1Gly169 (wildtype) and Slc11a1Asp169 (mutant/functional 
null) mice and with peritoneal macrophages isolated from these will be of interest to see 
whether the effect of Slc11a1 is also relevant in primary macrophages and the in vivo 
situation. This apprears likely since a recent study employing Slc11a1/Nramp11+/+ and 
Slc11a1/Nramp1-/-  mice in a model of Salmonella-induced colitis demonstrated that the 
Slc11a1 phenotype was associated with a pro-inflammatory immune response and an 
increased clearance of the bacteria (Valdez et al., 2008b). 
Of note, it has been demonstrated that Leishmania amazonensis is capable of up-regulating its 
ferrous iron importer LIT1 within phagolysosomes and that this regulation is accelerated in 
response to iron starvation by functional Slc11a1 (Huynh et al., 2006). Whether or not this 
also applies to intraphagolysosomal Salmonella is currently unknown. However, Salmonella 
expresses a set of virulence genes encoded within Salmonella pathogenicity island 2 as a 
specific response to Slc11a1-mediated iron starvation (Zaharik et al., 2002). In addition, 
Mycobacterium tuberculosis reportedly enhances siderophore production upon Slc11a1-
mediated iron deprivation (Jabado et al., 2003). 
The divalent cation transporters SitABCD and MntH have been shown to promote Salmonella 
growth in macrophages expressing Slc11a1 (Zaharik et al., 2004).  Here we show for the first 
time that EntC-dependent catecholate-type siderophore production promotes Salmonella 
growth in both Slc11a1-expressing and Slc11a1-deficient macrophages (Figure 8A). The 
ability of RAW-37 cells to effectively restrict wild type S. Typhimurium growth in 
phagocytes illustrates the capacity of Slc11a1 to limit the availability of cations in the 
vacuolar compartment beyond even the ability of high-affinity microbial iron acquisition 
systems to obtain them. 
Since iron plays a central role in the interaction between host and pathogen, affecting both 
microbial replication and the activation of cell-mediated immune pathways, a better 
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understanding of Slc11a1 transporter function and the further elucidation of the mechanisms 
linking metal ion redistribution to pro- and anti-inflammatory gene expression might enable 
the development of pharmacological strategies to specifically target Slc11a1 as a novel 
approach to control infections with intracellular pathogens such as Salmonella and 
Mycobacterium tuberculosis. 
We have provided evidence to support a dual role of the phagolysosomal transport protein 
Slc11a1 in promoting host resistance against intracellular microbes such as S. Typhimurium. 
By reducing the intracellular iron content of infected macrophages, Slc11a1 starves ingested 
bacteria of iron while concomitantly promoting the generation of antimicrobial effector 
molecules. These properties of Slc11a1 provide important insights into mechanisms by which 
nutrient withholding contributes to innate immunity. 
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Experimental procedures 
 
Cell culture 
RAW264.7 murine macrophage-like cells were originally isolated from Slc11a1-non-
functional BALB/c mice and obtained from the American Type Culture Collection. 
RAW264.7 cells were stably transfected by standard methods using the pHßA-1-neo 
expression plasmid containing the full-length Slc11a1 cDNA (RAW-37) or an antisense-
Slc11a1 construct (RAW-21) as described previously (Atkinson et al., 1999). Routinely, cells 
were grown in DMEM (containing 0.1 mg/ml Fe(NO3)3·9H2O; obtained from Biochrom, 
Berlin, Germany) containing 10% FCS, 2 mM L-glutamine and 50 µg/ml ampicillin at 37°C 
in humidified air containing 5% CO2 and periodically selected for plasmid retention using 
G418 (Invitrogen). Stable expression of Slc11a1 in RAW-37 phagocytes was confirmed by 
immunoblotting (Supplementary figure 5, upper panel). 
For infection experiments, 1x106 RAW-21/37 cells were seeded into 6-well plates in 2 ml of 
DMEM containing 10% FCS, 2 mM L-glutamine and 50 µg/ml ampicillin. S. Typhimurium 
strain C5RP4 (kindly provided by Dr. Pietro Mastroeni, Cambridge University, Cambridge, 
United Kingdom), a virulent wild-type isolate carrying natural resistance to ampicillin, was 
used for experiments unless otherwise indicated and grown in Luria-Bertani (LB) broth 
(obtained from Sigma) containing 50 µg/ml ampicillin to late-logarithmic phase. After 
preincubation of S. Typhimurium in complete DMEM at 37°C for 20 minutes, RAW-21/37 
cells were infected with S. Typhimurium at a multiplicity of infection (MOI) of 10 for 1 hour 
exactly as described (Nairz et al., 2007). Control cells were treated with complete DMEM 
without any microbes. After 1 hour, RAW-21/37 cells were washed three times with 
phosphate-buffered saline (PBS; purchased from Invitrogen) and incubated in 2 ml of 
complete DMEM additionally containing 20 µg/ml of gentamicin (Gibco) in order to kill 
extracellular bacteria. Thereafter, macrophages were stimulated with recombinant murine 
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IFN-γ (50 U/ml; obtained from R&D), whereas controls were treated with PBS as solvent. 
After incubation for an additional 23 hours, RAW-21/37 cells were washed three times in 
PBS and subjected to RNA or protein isolation. Alternatively, cells were treated with 
lipopolysaccharide (LPS; obtained from Sigma) and IFN-γ and subjected to RNA isolation. 
For certain experiments, RAW-21/37 cells were cultured in complete DMEM without 
any antibiotics and infected with S. Typhimurium strain MLC446 (wild-type; corresponding 
to ATCC 14028s) or isogenic mutant derivatives MLC619 (entC::aph; single mutant) and 
MLC774 (entC::aph sit::bla feo::Tn10 (Tetr); triple mutant). Mutant strains were constructed 
and grown as described (Crouch et al., 2008) and used as detailed above. 
For quantification of intracellular bacteria by means of gentamicin protection, RAW-
21/37 cells were infected as described above and stimulated with IFN-γ, serial concentrations 
of human holo-transferrin or ferrous sulfate (all from Sigma). In experiments using synthetic 
murine hepcidin 1 (1 µM; purchased from PeptaNova), a blocking monoclonal anti-TfR1 
antibody and desferrioxamine (DFO; added at a concentration of 50 µM and purchased from 
Sigma), cells were pre-treated for 8 hours and subsequently infected for an additional 12 
hours. The appropriate solvent or isotype control antibody served as controls. After an 
infection period of 24 hours, cells were washed 5 times with PBS, lysed in 0.5% deoxycholic 
acid (Sigma) and plated under sterile conditions in appropriate dilutions onto LB agar plates. 
 
Quantitative Reverse Transcription PCR (qPCR) 
Preparation of total RNA from RAW-21/37 macrophages was performed by a guanidinium-
isothiocyanate-phenol-chloroform based extraction method exactly as described (Ludwiczek 
et al., 2007). Quantification of mRNA expression was carried out by means of quantitative 
reverse transcription PCR (qPCR), which was performed exactly as described (Ludwiczek et 
al., 2004). Amplifications conditions were as follows: 95°C for 10 min, 40 cycles of 95°C for 
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15 s, 60°C for 60 s. The following primers and TaqMan probes (Microsynth), the latter 
carrying 5’-FAM and 3’-BHQ1-labels, were used: 
mu-Dmt1: 5’-CCAGCCAGTAAGTTCAAGGATCC-3’, 5’-GCGTAGCAGCTGATCTGGG-
3’, 5’-TGGCCTCGCGCCCCAACA-3’, 
mu-TfR1: 5’-CGCTTTGGGTGCTGGTG-3’, 5-GGGCAAGTTTCAACAGAAGACC-3’, 5’-
CCCACACTGGACTTCGCCGCA-3’, 
mu-Fpn1: 5’-CTACCATTAGAAGGATTGACCAGCT-3’, 5’-
CAAATGTCATAATCTGGCCGA-3’, 5’-CAACATCCTGGCCCCCATGGC-3’, 
mu-Hamp: 5’-TGTCTCCTGCTTCTCCTCCTTG-3’, 5’-
AGCTCTGTAGTCTGTCTCATCTGTTG-3’, 5’-
CAGCCTGAGCAGCACCACCTATCTCC-3’, 
mu-Hmox1: 5’-GTGATGGAGCGTCCACAGC-3’, 5’-TGGTGGCCTCCTTCAAGG-3’, 5’-
CGACAGCATGCCCCAGGATTTGTC-3’, 
mu-H-ferritin: 5’-GCGAGGTGGCCGAATCT-3’, 5’-CAGCCCGCTCTCCCAGT-3’, 5’- 
CCTGCAGGATATAAAGAAACCAGACCGTGA-3’, 
mu-Flvcr: 5’-ATCTGGAACCTGTGCAGAAACA-3’, 5’-
ATTGAATAAAATGCTCCAGTCATGAT-3’, 5’-
CCCCTTTGTTCTCCTGCTGGTCAGTTATG-3’, 
mu-iNOS: 5’-CAGCTGGGCTGTACAAACCTT-3’, 5’-CATTGGAAGTGAAGCGTTTCG-
3’, 5’-CGGGCAGCCTGTGAGACCTTTGA-3’, 
mu-phox-p47: 5’-GAGGCGGAGGATCCGG-3’, 5’-TCTTCAACAGCAGCGTACGC-3’, 5’- 
CAACTACGCAGGTGAACCGTATGTAACCATCA-3’, 
mu-TNF-α: 5’- TTCTATGGCCCAGACCCTCA-3’, 5’-TTGCTACGACGTGGGCTACA-3’, 
5’- CTCAGATCATCTTCTCAAAATTCGAGTGACAAGC-3’, 
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mu-IL-6: 5’- TGTTCTCTGGGAAATCGTGGA-3’, 5’-
AAGTGCATCATCGTTGTTCATACA-3’, 5’- 
ATGAGAAAAGAGTTGTGCAATGGCAATTCTG-3’, 
mu-IL-10: 5’- CCAGAGCCACATGCTCCTAGA-3’, 5’-
TGGTCCTTTGTTTGAAAGAAAGTCT-3’, 5’- TGCGGACTGCCTTCAGCCAGG-3’, 
mu-IL-18: 5’-GACTCTTGCGTCAACTTCAAGGA-3’, 5’-
TTGTCTGATTCCAGGTCTCCATT-3’, 5’-
TGATGTTTATTGACAACACGCTTTACTTTATACCTGAAGA-3’, 
mu-IL-23-p19: 5’-AGCGGGACATATGAATCTACTAAGAGA-3’, 5’-
GTCCTAGTAGGGAGGTGTGAAGTTG-3’, 5’- CCAGTTCTGCTTGCAAAGGATCCGC-
3’ 
mu-IL-23-p40: 5’-GACCATCACTGTCAAAGAGTTTCTAGAT-3’, 5’-
AGGAAAGTCTTGTTTTTGAAATTTTTTAA-3’, 5’-
CCACTCACATCTGCTGCTCCACAAGAAG-3’, 
mu-Mcp-1: 5’-CTTCTGGGCCTGCTGTTCA-3’, 5’-CCAGCCTACTCATTGGGATCA-3’, 
5’-CTCAGCCAGATGCAGTTAACGCCCC-3’, 
mu-Mip-1α: 5’-AGCTGACACCCCGACTGC-3’, 5’-GTCAACGATGAATTGGCGTG-3’,  
5’-TGCTGCTTCTCCTACAGCCGGAAGAT-3’, 
mu-18S rRNA: 5’-CCTGCCCTTTGTACACACCG-3’, 5’-CGATCCGAGGGCCTCAC-3’, 
5’-CCGTCGCTACTACCGATTGGATGGTTT-3’. 
Unless otherwise indicated, qPCR data are expressed as mean ± SD of five independent 
experiments. 
 
Immunoblot analysis 
Protein extracts from RAW-21/37 cells were prepared using the radioimmunoprecipitation 
assay (RIPA) buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 50 
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mM Tris [tris(hydroxymethyl)aminomethane] HCl, pH 8.0;) supplemented with 1 µg/ml 
aprotinin and 1 µg/ml leupeptin (all from Sigma). 10 - 40 µg of total protein were run on 8 - 
15% SDS-polyacrylamide gels and immunoblotting was performed exactly as described 
(Theurl et al., 2006) using a mouse anti-human TfR1 antibody (1:1000; Zymed), a rabbit anti-
human ferritin antibody (1:800; Dako), a rabbit anti-human ferroportin 1 antibody (1:400; 
Eurogentec), a rabbit anti-Slc11a1/Nramp1 antibody (1:1000; (Atkinson et al., 1999)), a 
rabbit anti-rat Hmox1 (1:2000; Stressgen) or a rabbit anti-Actin antibody (1:1000; Sigma), the 
latter used as a loading control. 
 
Quantification of iron uptake and release by macrophages 
For macrophage iron uptake and release studies, RAW-21/37 cells were infected with S. 
Typhimurium as detailed above. Following three washing cycles with serum-free, HEPES-
buffered DMEM (2 mM L-glutamine, 50 µg/ml ampicillin, 25 mM HEPES, pH 7.4), cells 
were then incubated therein. For determination of the uptake of non-transferrin-bound iron 
(NTBI), 5 µM 59Fe-citrate (DuPont New England Nuclear) were used, whereas for the 
measurement of transferrin-bound iron (TBI) acquisition, 59Fe-labeled transferrin was added 
at a concentration of 12.5 µg/ml exactly as described (Ludwiczek et al., 2003). For iron 
release experiments, cells were first incubated with 5 µM 59Fe-citrate for 4 hours to allow for 
iron loading and then washed four times and repleted with 2 ml of serum-free, HEPES-
buffered DMEM. After an additional incubation for 2 hours, cellular iron release was 
measured by means of a γ-counter as described (Nairz et al., 2008). In parallel to each iron 
release study, a trypan-blue exclusion assay was performed to ensure that neither treatment 
interfered with the integrity of the RAW-21/37 cell surface membrane. 
 
Determination of iron acquisition by S. Typhimurium 
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RAW-21/37 cells were seeded in complete DMEM and infected with S. Typhimurium strain 
C5RP4 at an MOI of 10 as detailed above. Thereafter, cells were washed three times and 
repleted with serum-free, HEPES-buffered DMEM. After the addition of either 5 µM 59Fe-
citrate or 12.5 µg/ml of 59Fe-labeled transferrin, macrophages were incubated for additional 4 
hours. Thereafter, intracellular bacilli were harvested according to a modified protocol as 
described (Olakanmi et al., 2002). Briefly, RAW-21/37 cells were lysed in 0.1% SDS in the 
presence of 10,000 U/ml DNase-I (Invitrogen) and EDTA-free protease inhibitor (Roche). 
Cell lysates were withdrawn into microfuge tubes and incubated at room temperature for 10 
min, and aliquots of 50 µl volume were transferred into γ-counter tubes for assessment of total 
iron in the macrophage lysate. The released bacilli were centrifuged at 10,000 g for 10 min at 
room temperature. The supernatant was removed, and the bacterial pellet was washed three 
times with 0.01% SDS in DMEM containing 1 mg/ml proteinase K (Roche). The bacilli were 
finally resuspended in 500 µl of 0.01% SDS in DMEM containing 1 mg/ml proteinase K. 
Fifty µl of the bacterial suspension were plated in serial dilutions onto agar plates to quantify 
released bacteria while the remaining volume was filtered through centrifugal filter devices 
with a PDVF membrane of 0.22 µm pore size (Millipore). The filters containing the trapped 
bacilli were washed five times and placed into a γ-counter tube. The amount of Salmonella-
associated 59Fe was assessed using a γ-counter. No association of 59Fe to S. Typhimurium, 
heat-inactivated at 70°C for 20 min, could be detected. The incorporation of 59Fe into ferritin 
multimers was investigated exactly as described REF. 
 
Detection of cytokines, ferritin content, nitrite and total oxidative capacity 
Concentrations of TNF, IL-1ß, IL-6 and IL-10 in cell culture supernatants were determined by 
specific ELISA kits (BD Pharmingen). Ferritin content in cytoplasmatic extracts was 
measured by a specific ELISA kit (Kamiya Biomedical Company) and normalized for total 
cytoplasmatic protein content as determined by the BCA method (Pierce). Determination of 
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nitrite, an oxidation product of NO, was carried out to monitor the production of RNS using 
the Griess reagent (Merck) as described (Fritsche et al., 2001). The formation of ROS was 
studied by measuring total oxidative capacity (TOC) in culture supernatants with the TOC Kit 
(Tatzber KG), which is based on the peroxidase-mediated oxidation of tetramethylbenzidine 
(Weiss et al., 2003). 
 
Electrophoretic mobility shift assays (EMSA) 
Extraction of nuclear proteins was carried out as described (Schreiber et al., 1989). For the 
preparation of radiolabeled probes representing standard consensus sequences of various 
transcription factors known to mediate the response of murine macrophages to LPS/IFN-γ 
stimulation, the oligonucleotides used were as follows: Interferon regulatory factor 1 (IRF-1) 
sense 5’-GGAAGCGAAAATGAAATTG-3’, IRF-1 antisense 5’-
TGAGTCAATTTCATTTTCG-3’; 
NF-κB sense 5’-AGCTTCAGAGGGGACTTTCCGAGAGG-3’, NF-κB antisense 5’-
TCGACCTCTCGGAAAGTCCCCTCTGA-3’; STAT-1 sense 5’-
CATGTTATGCATATTCCTGTAAGTG-3’, STAT-1 antisense 5’-
CGTGCACTTACAGGAATATGCATA-3’; STAT-3 sense 5'-
GATCCTTCTGGGAATTCCTA-3', STAT-3 antisense 5'-GATCTAGGAATTCCCAGAAG-
3'. For the preparation of double-stranded probes, oligomers were annealed, and overhanging 
ends were filled with [α-32P]dCTP (Amersham) and the three other non-radiolabeled dNTPs 
(Pharmacia) using Klenow enzyme (Amersham) as described (Fritsche et al., 2003). For the 
preparation of unlabeled competitors, dCTP was used. A total of 10 µg of nuclear extracts 
were preincubated with 2 µg of double-stranded poly(dI-dC)·poly(dIdC) (Pharmacia) on ice 
for 10 min before addition of 2 ng of the radiolabeled oligonucleotide probe (50,000 cpm/ng). 
For competition studies, a 30-fold excess of unlabeled oligonucleotide probe was added to the 
nuclear extracts derived from RAW-21 cells (stimulated with S. Typhimurium and IFN-γ for 
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24 hours) 10 min before addition of the radioactive probe. The DNA binding reactions were 
performed in the presence of 200 mM HEPES (pH 7.8), 10 mM EDTA, and 10 mM DDT for 
20 min on ice. Samples were separated on 6% nondenaturing polyacrylamide gels, which 
were subsequently exposed by means of autoradiography. 
 
Statistical analysis 
Statistical analysis was carried out using a SPSS statistical package. Calculations for 
statistical differences were carried out by parametric ANOVA test using Bonferroni 
correction for multiple tests or, where appropriate, by nonparametric Kruskal-Wallis test. 
Unless otherwise indicated, statistically significant differences between means are indicated 
as follows: * P < 0.05 for infected/stimulated RAW-21 macrophages in comparison to RAW-
21 controls; ° P < 0.05 for infected/stimulated RAW-37 in comparison to untreated RAW-37 
cells; # P < 0.05 for the comparison of RAW-21 and RAW-37 cells subjected to the same 
treatment. 
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Figure legends 
 
Figure 1. 
Effects of Slc11a1 on iron acquisition and iron release by Salmonella-infected macrophages 
Slc11a1-non-functional RAW-21 cells (light grey bars) and Slc11a1-functional RAW-37 cells 
(dark grey bars) were infected with S. Typhimurium (S. tm.) at a MOI of 10 and stimulated 
with 50 U/ml IFN-γ for 24 hours. TfR1 and Fpn1 mRNA levels (Figures 1A and 1C, 
respectively) were determined by qPCR. Values were corrected for the amount of 18S 
ribosomal RNA, which was determined in parallel. Results are shown as relative differences 
of this ratio in comparison to unstimulated Slc11a1-expressing RAW-37 control macrophages 
(=1.0). Data are expressed as mean ± SD of five independent experiments. The uptake of TBI 
as well as iron release (depicted in Figures 1B and 1D and, respectively) were determined as 
described in ‘Experimental procedures’. Data are shown as mean ± SD of five independent 
experiments performed in duplicates and are expressed as fold change in the relative iron 
uptake/release in comparison to RAW-37 controls (=1.0). * P < 0.05 for infected/stimulated 
RAW-21 macrophages in comparison to RAW-21 controls; ° P < 0.05 for infected/stimulated 
RAW-37 in comparison to untreated RAW-37 cells; # P < 0.05 for the comparison of RAW-
37 and RAW-21 cells subjected to the same treatment. 
 
Figure 2. 
Regulation of TfR1 and Fpn1 protein levels in Salmonella-infected RAW-21 and RAW-37 cells 
Slc11a1-non-expressing RAW-21 cells and Slc11a1-expressing RAW-37 cells were infected 
with Salmonella and stimulated with IFN-γ exactly as described in the legend to Figure 1. 
Whole cell lysates were analysed by immunoblotting using specific antibodies to TfR1 (upper 
panel) and Fpn1 (middle panel). Equal loading of protein extracts was confirmed by re-
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probing membranes with an anti-Actin antibody (lower panel). One of four representative 
immunoblot experiments is shown. 
 
Figure 3. 
Effects of Slc11a1 on ferritin expression and on intracellular iron content in Salmonella-
infected macrophages 
RAW-21 and RAW-37 cells were infected with Salmonella and activated with IFN-γ exactly 
as described in the legend to Figure 1. The mRNA levels of H-ferritin were determined by 
qPCR (Figure 3A). Results are shown as relative differences of this ratio in comparison to the 
unstimulated control macrophages (=1.0). The total cellular iron content was determined by 
means of atomic absorption spectrometry and normalized for the protein content (Figure 3B). 
Data are expressed as means ± SD of five independent experiments. Statistically significant 
differences are indicated as described in the legend to figure 1. 
 
Figure 4. 
Impact of Slc11a1 on macrophage immune effector functions after IFN-γ stimulation 
RAW-21 and RAW-37 cells were stimulated with IFN-γ and/or infected with Salmonella for 
24 hours. Culture supernatants were analyzed for RNS (as determined by measuring nitrite 
levels, Figure 4A), TNF-α (Figure 4B), IL-6 (Figure 4C) and IL-10 (Figure 4D) as described 
in ‘Experimental procedures’. Data are shown as mean ± SD of four to five independent 
experiments. Statistically significant differences are indicated as described in the legend to 
figure 1. 
 
Figure 5. 
Impact of Slc11a1 on the intracellular survival of Salmonella 
Page 38 of 50
Slc11a1 limits Salmonella iron access 39 
RAW-21 and RAW-37 cells were infected with Salmonella for the indicated periods (Figure 
5A) or infected for 24 hours and activated with IFN-γ (Figure 5B). Bacterial load was 
determined by selective plating as described in ‘Experimental procedures’. 
 
Figure 6. 
Impact of Slc11a1 on macrophage immune effector functions in the presence of exogenous 
iron perturbations 
In additional experiments, macrophages were infected with Salmonella and exposed to serial 
concentrations of human holo-transferrin. Bacterial load was determined by selective plating 
(Figure 6A). Cell culture supernatants were analyzed for the formation of nitrite, TNF-α, IL-
10 and IL-6 as described (Figures 6B, C, D and E, respectively). Statistically significant 
differences are indicated as described 
 
Figure 7. 
Contributions of Fpn1-mediated iron export and of TBI-uptake to Slc11a1-dependent 
macrophage functions 
RAW-21 and RAW-37 cells were pre-treated for 8 hours with FeSO4, DFO, synthetic Hamp, 
a blocking α-TfR1 antibody or the appropriate control. Subsequently, cells were infected with 
Salmonella for 12 hours. Intracellular bacteria were enumerated (Figure 7A) and 
concentrations of TNF-α (Figure 7B) and of nitrite (Figure 7C) in supernatants were 
measured by a specific ELISA or the Griess reaction, respectively. 
 
Figure 8. 
Limitation of iron availability for intramacrophage Salmonella in the presence of Slc11a1 
The acquisition of NTBI (Figure 8A) and TBI (Figure 8B) by intramacrophage bacilli was 
determined as described in ‘Experimental procedures’  using S. Typhimurium engulfed by 
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Slc11a1-non-functional RAW-21 in comparison to Slc11a1-functional RAW-37 phagocytes. 
Data are shown as means ± SD of five independent experiments and normalized for the 
number of bacteria as determined by selective plating. 
 
Figure 9. 
Antibacterial effects in RAW-21 and RAW-37 cells infected with iron-uptake mutant 
Salmonella 
RAW-21 and RAW-37 phagocytes were infected with S. Typhimurium wild-type strain as 
well as with isogenic entC and entC sit feo mutant derivatives and treated with PBS or 12.5 
µg/ml holo-transferrin. The intracellular survival of bacteria was enumerated after 20 hours, 
and data are presented as relative values in comparison to solvent-treated RAW-37 cells 
infected with wild-type Salmonella (Figure 9A). Culture supernatants were analyzed for the 
concentrations of TNF-α (Figure 9B) and nitrite (9C). 
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